Artificial Vital organs and Medical Bionics Market by Product Types (Artificial Vital organs -Artificial Heart – Total Artificial Heart, Artificial Kidney – Hemodialysis Machines, Artificial Liver – Artificial Pancreas, Insulin Pumps, Artificial Lungs, Heart-Lung -pass Machines, Oxygenators, Bionics – Ear Bionics, Vision Bionics, Exoskeletons, Bionic Limbs, Bionic Leg, Bionic Hand, Brain Bionics, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Cardiac Bionics, Ventricular Assist Device, Left Ventricular Assist Device, Right Ventricular Assist Device, Heart Valves – Mechanical Heart Valves, Biological Tissue Valves, Transcatheter Heart Valves) and Forecast 2017-2021

Artificial Vital organs and Medical Bionics Market by Product Types (Artificial Vital organs -Artificial Heart – Total Artificial Heart, Artificial Kidney – Hemodialysis Machines, Artificial Liver – Artificial Pancreas, Insulin Pumps, Artificial Lungs, Heart-Lung -pass Machines, Oxygenators, Bionics – Ear Bionics, Vision Bionics, Exoskeletons, Bionic Limbs, Bionic Leg, Bionic Hand, Brain Bionics, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Cardiac Bionics, Ventricular Assist Device, Left Ventricular Assist Device, Right Ventricular Assist Device, Heart Valves – Mechanical Heart Valves, Biological Tissue Valves, Transcatheter Heart Valves) and Forecast 2017-2021

The artificial organs are devices implanted or integrated into a human body in order to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions for the patient to return to a normal life as soon as possible, whereas bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology. The increasing mortality rate of patients awaiting organ transplant has intensified the demand for artificial organs. The artificial vital organs and medical bionics market is undergoing impressive growth across the globe due to increase in the gap between patients awaiting organ transplant and the availability of donor organs.

The global artificial vital organs and medical bionics market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).

The global artificial vital organs and medical bionics market segmentation is based on product types (artificial vital organs -artificial heart – total artificial heart, artificial kidney – hemodialysis machines, artificial liver – artificial pancreas, insulin pumps, artificial lungs, heart-lung bypass machines, oxygenators, bionics – ear bionics, vision bionics, exoskeletons, bionic limbs, bionic leg, bionic hand, brain bionics, spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, cardiac bionics, ventricular assist device, left ventricular assist device, right ventricular assist device, heart valves – mechanical heart valves, biological tissue valves, transcatheter heart valves).

The global artificial vital organs and medical bionics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global artificial vital organs and medical bionics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global artificial vital organs and medical bionics market and profiled in this report include Abbott Diabetes Care, AbioMed, Baxter International, Fresenius Medical Care, Thoratec Corporation, Ottobock Healthcare, SynCardia Systems, Inc., WorldHeart Corporation and others.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Artificial Vital Organs and Medical Bionics Market

1. Product Type
1.1. Artificial Vital Organs
1.1.1. Artificial Heart
1.1.1.1. Total Artificial Heart (TAH)
1.1.2. Artificial Kidney
1.1.2.1. Hemodialysis Machines
1.1.3. Artificial Liver
1.1.4. Artificial Pancreas
1.1.4.1. Insulin Pumps
1.1.5. Artificial Lungs
1.1.5.1. Heart-Lung Bypass Machines
1.1.5.2. Oxygenators
1.2. Bionics
1.2.1. Ear Bionics (Cochlear Implants)
1.2.2. Vision Bionics
1.2.3. Exoskeletons
1.2.4. Bionic Limbs
1.2.4.1. Bionic Leg
1.2.4.2. Bionic Hand
1.2.5. Brain Bionics
1.2.5.1. Spinal Cord Stimulators
1.2.5.2. Deep Brain Stimulators
1.2.5.3. Vagus Nerve Stimulators
1.2.6. Cardiac Bionics
1.2.7. Ventricular Assist Device (VAD)
1.2.8. Left Ventricular Assist Device (LVAD)
1.2.9. Right Ventricular Assist Device (RVAD)
1.2.10. Heart Valves
1.2.10.1. Mechanical Heart Valves
1.2.10.2. Biological Tissue Valves
1.2.10.3. Transcatheter Heart Valves

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Abbott Diabetes Care, Inc.
3.2. Abiomed, Inc.
3.3. Asahi Kasei Medical Co., Ltd.
3.4. Baxter International, Inc.
3.5. Cyberonics, Inc.
3.6. Edwards Lifesciences Corporation
3.7. Ekso Bionics
3.8. F. Hoffmann-La Roche Ltd
3.9. Fresenius Medical Care AG & Co. Kgaa
3.10. Gambro AB
3.11. Iwalk, Inc.
3.12. Jarvik Heart, Inc.
3.13. Medtronic, Inc.
3.14. Micromed Cardiovascular, Inc.
3.15. Nikkiso Co., Ltd.
3.16. Ossur Hf
3.17. Ottobock Healthcare Gmbh
3.18. Second Sight Medical Products, Inc.
3.19. Syncardia Systems, Inc.
3.20. Thoratec Corporation
3.21. Touch Bionics, Inc.
3.22. Vital Therapies, Inc.
3.23. WorldHeart Corporation

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*